Infectious Disease Testing market is segmented by players, region (country), by Technology and by Application. Players, stakeholders, and other participants in the global Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by Application for the period 2017-2028.
Segment by Technology
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
DNA Sequencing & NGS
DNA Microarrays
Other
Segment by Application
Hospitals/Clinical Laboratories
Reference Laboratories
Academic/Research Institutes
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Diagnostics
Abbott
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Abaxis
Acon Laboratories
Avioq
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies
Maxim Biomedical